Reducing carcinogen levels in cigarette smoke [3]

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 10, 2007, Pages 2170-

  Mirvish, Sidney S ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BENZO[A]PYRENE; CARCINOGEN; FERTILIZER; NICOTINE; NITRATE; NITRITE; NITROSAMINE; POLYCYCLIC AROMATIC HYDROCARBON;

CANCER RISK; CATALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COMBUSTION; HEART DISEASE; INCIDENCE; LETTER; LUNG CANCER; MEDICAL RESEARCH; MORTALITY; NONHUMAN; PRIORITY JOURNAL; STROKE;

DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUNG NEOPLASMS; NITROSAMINES; POLYCYCLIC HYDROCARBONS, AROMATIC; RISK FACTORS; SMOKE; SMOKING; TOBACCO;

EID: 35448958801     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0586     Document Type: Letter

References (12)

1. Gritz ER, Sarna L, Dresler C, Healton CG. Building a United front: aligning the agendas for tobacco control, lung cancer research, and policy. Cancer Epidemiol Biomarkers Prev 2007;16:859-63.
2. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003;3:733-44.
3. Hoffmann D, Brunnemann KD, Prokopczyk B, Djordjevic MV. Tobacco-specific N-nitrosamines and areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J Toxicol Environ Health 1994;41:1-52.
4. Wu W, Zhang L, Jain RB, Ashley DL, Watson CH. Determination of carcinogenic tobacco-specific nitrosamines in mainstream smoke from U.S.-brand and non-U.S.-brand cigarettes from 14 countries. Nicotine Tob Res 2005;7:443-51.
5. Fischer S, Spiegelhalder B, Preussmann R. Preformed tobacco-specific nitrosamines in tobacco - role of nitrate and influence of tobacco type. Carcinogenesis 1989;10:1511-17.
6. Fischer S, Spiegelhalder B, Preussmann R. Tobacco-specific nitrosamines in mainstream smoke of West German cigarettes - tar alone is not a sufficient index for the carcinogenic potential of cigarette smoke. Carcinogenesis 1989;10:169-73.
7. Hoffmann D, Hoffmann I, El Bayoumy K. The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem Res Toxicol 2001;14:767-90.
8. Fischer S, Spiegelhalder B, Eisenbarth J, Preussmann R. Investigations on the origin of tobacco-specific nitrosamines in mainstream smoke of cigarettes. Carcinogenesis 1990;11:723-30.
9. Fischer S, Spiegelhalder B, Preussmann R. Influence of smoking parameters on the delivery of tobacco-specific nitrosamines in cigarette smoke - a contribution to relative risk evaluation. Carcinogenesis 1989;10:1059-66.
10. Foulds J, Ramstrom L, Burke M, Fagerstrom K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 2003;12:349-59.
11. Whong WZ, Stewart JD, Wang YK, Ong T. Acid-mediated mutagenicity of tobacco snuff: its possible mechanism. Mutat Res 1987;177:241-46.
12. National Cancer Institute. Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Smoking and Tobacco Control, Monograph 13. Washington (DC): National Cancer Institute; 2001.